Between January and October 2018, Russia produced 276.2 mln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 1.9% higher than that of the same period of 2017. The positive dynamics are mostly due to the active work of manufacturers. In physicals terms though, Russia produced 3.3 bln units of pharmaceuticals, which is 9.4% lower than that of the same period of 2017.

Between January and September 2018, Russia imported 68.9 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 26.8% higher than that of the same period of 2017. In physical terms, the dynamics are -8.5%, and the imported volume is 8,300 tons.

Between January and September 2018, Russia imported 47.4 bln RUB worth of veterinary products (free circulation prices), which is in monetary terms 15.3% higher than that of the same period of 2017. The import of feed supplements amounted to 27.3 bln RUB, with a 16.9% increase. The import of veterinary drugs amounted to 18.7 bln RUB, with a 13.6% increase. The import of veterinary APIs amounted to 1.5 mln RUB, with a 15% increase.

Between January and September 2018, Russia imported 376.6 bln RUB worth of ready-made pharmaceutical drugs (free circulation prices), which is in monetary terms 1% higher than that of the same period of 2017, and 81.1 bln RUB worth of in-bulk drugs, which is 16% higher than that of the same period of 2017. The total dynamics in monetary terms are +3.3%.

Between January and September 2018, there was not any major changes in the ranking of the top pharmaceutical distributors, except for the top places. The first three places have changed, with Puls having reached first place after quite a struggle. The changes are not that surprising, which we discussed in our previous review (Q1 – Q2 results).